| Literature DB >> 3169375 |
G R Corazza1, M Ventrucci, A Strocchi, M Sorge, L Pranzo, R Pezzilli, G Gasbarrini.
Abstract
In twelve patients affected by small bowel bacterial overgrowth, diagnosed by means of the lactulose hydrogen breath test, the therapeutic efficacy of a non-absorbable derivative of rifamycin, rifaximin, was evaluated. This study showed that this drug has a satisfactory therapeutic efficacy in contaminated small bowel syndrome and, at the doses tested, is free of side-effects.Entities:
Mesh：
Substances：
Year: 1988 PMID： 3169375 DOI： 10.1177/030006058801600410
Source DB: PubMed Journal: J Int Med Res ISSN： 0300-0605 Impact factor: 1.671